Literature DB >> 17608270

Simultaneous surgical management of achalasia and morbid obesity.

Robert W O'Rourke1, Blair A Jobe, Donn H Spight, John G Hunter.   

Abstract

Achalasia presenting in the context of morbid obesity is rare. The case is presented of a woman with achalasia and morbid obesity who was treated with simultaneous laparoscopic esophageal myotomy and gastric bypass. The sparse literature addressing these rare patients is reviewed and management considerations discussed. Simultaneous laparoscopic esophageal myotomy and gastric bypass is safe, feasible and provides good results.

Entities:  

Mesh:

Year:  2007        PMID: 17608270     DOI: 10.1007/s11695-007-9095-1

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  14 in total

1.  The effects of laparoscopic adjustable gastric banding on the proximal pouch and the esophagus.

Authors:  D Peternac; R Hauser; M Weber; O Schöb
Journal:  Obes Surg       Date:  2001-02       Impact factor: 4.129

2.  A model for gastric banding in the treatment of morbid obesity: the effect of chronic partial gastric outlet obstruction on esophageal physiology.

Authors:  Robert W O'Rourke; Ann K Seltman; Eugene Y Chang; Kevin M Reavis; Brian S Diggs; John G Hunter; Blair A Jobe
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

3.  Treatment of morbid obesity with laparoscopic adjustable gastric banding affects esophageal motility.

Authors:  H G Weiss; H Nehoda; B Labeck; M D Peer-Kühberger; P Klingler; M Gadenstätter; F Aigner; G J Wetscher
Journal:  Am J Surg       Date:  2000-12       Impact factor: 2.565

4.  A decision analysis of the optimal initial approach to achalasia: laparoscopic Heller myotomy with partial fundoplication, thoracoscopic Heller myotomy, pneumatic dilatation, or botulinum toxin injection.

Authors:  D R Urbach; P D Hansen; Y S Khajanchee; L L Swanstrom
Journal:  J Gastrointest Surg       Date:  2001 Mar-Apr       Impact factor: 3.452

5.  Manometric abnormalities and gastroesophageal reflux disease in the morbidly obese.

Authors:  Dennis Hong; Yashodhan S Khajanchee; Natasha Pereira; Barbara Lockhart; Emma J Patterson; Lee L Swanstrom
Journal:  Obes Surg       Date:  2004 Jun-Jul       Impact factor: 4.129

6.  Early results of laparoscopic Heller myotomy do not necessarily predict long-term outcome.

Authors:  Mark Bloomston; Alan Durkin; H Worth Boyce; Milton Johnson; Alexander S Rosemurgy
Journal:  Am J Surg       Date:  2004-03       Impact factor: 2.565

7.  Achalasia in the context of morbid obesity: a rare but important association.

Authors:  Gidon Almogy; Gary J Anthone; Peter F Crookes
Journal:  Obes Surg       Date:  2003-12       Impact factor: 4.129

8.  Long-term results in surgically managed esophageal achalasia.

Authors:  R A Malthaner; T R Tood; L Miller; F G Pearson
Journal:  Ann Thorac Surg       Date:  1994-11       Impact factor: 4.330

9.  Perioperative morbidity associated with bariatric surgery: an academic center experience.

Authors:  Robert W O'Rourke; Jason Andrus; Brian S Diggs; Mark Scholz; Donald B McConnell; Clifford W Deveney
Journal:  Arch Surg       Date:  2006-03

10.  The duodenal switch operation for the treatment of morbid obesity.

Authors:  Gary J Anthone; Reginald V N Lord; Tom R DeMeester; Peter F Crookes
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

View more
  3 in total

Review 1.  The surgical management of achalasia in the morbid obese patient.

Authors:  P Marco Fisichella; George Orthopoulos; Amy Holmstrom; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2015-03-11       Impact factor: 3.452

2.  Morbid obesity with achalasia: a surgical challenge.

Authors:  Monika E Hagen; Micheal Sedrak; Oliver J Wagner; Garth Jacobsen; Mark Talamini; Santiago Horgan
Journal:  Obes Surg       Date:  2010-10       Impact factor: 4.129

3.  Achalasia after bariatric Roux-en-Y gastric bypass surgery reversal.

Authors:  Mouhanna Abu Ghanimeh; Ayman Qasrawi; Omar Abughanimeh; Sakher Albadarin; Wendell Clarkston
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.